Literature DB >> 18651872

Transplant-associated Ochroconis gallopava infections.

S Shoham1, L Pic-Aluas, J Taylor, K Cortez, M G Rinaldi, Y Shea, T J Walsh.   

Abstract

BACKGROUND: Ochroconis gallopava is a neurotropic dematiaceous mold that causes respiratory and central nervous system (CNS) infection in domestic poultry and in immunocompromised patients. We recently treated 3 solid organ transplant (SOT) recipients for pulmonary Ochroconis infections with successful outcome, prompting us to review the literature on this unique pathogen.
METHODS: We reviewed all published cases of O. gallopava infections in SOT recipients and analyzed the impact of CNS infection on the outcome.
RESULTS: In addition to the 3 new cases reported here, 9 published cases of Ochroconis infection were analyzed. The disease involved the lungs only in 5/12 (42%) of patients, brain in 6/12 (50%) patients, and lung and skin in 1 patient. Survival was significantly reduced with brain infection (33% vs. 100%; P<0.03; Fisher's exact test).
CONCLUSIONS: O. gallopava may infect SOT recipients with a particular tropism for the CNS. Early recognition of O. gallopava pulmonary infection is important, as the prognosis is excellent before dissemination to the brain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18651872     DOI: 10.1111/j.1399-3062.2008.00327.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  10 in total

1.  Antifungal susceptibility patterns of opportunistic fungi in the genera Verruconis and Ochroconis.

Authors:  S Seyedmousavi; K Samerpitak; A J M M Rijs; W J G Melchers; J W Mouton; P E Verweij; G S de Hoog
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

2.  Ochroconis humicola coexisting with esthesioneuroblastoma: an incidental coloniser or allergen?

Authors:  Harsimran Kaur; Shivaprakash M Rudramurthy; Satyawati Mohindra; Sunita Gupta; Arunaloke Chakrabarti
Journal:  Mycopathologia       Date:  2014-06-21       Impact factor: 2.574

3.  Ochroconis calidifluminalis, a sibling of the neurotropic pathogen O. gallopava, isolated from hot spring.

Authors:  Kyoko Yarita; Ayako Sano; Kittipan Samerpitak; Katsuhiko Kamei; G Sybren de Hoog; Kazuko Nishimura
Journal:  Mycopathologia       Date:  2010-03-07       Impact factor: 2.574

4.  What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis?

Authors:  Dimitrios P Kontoyiannis; David S Perlin; Emmanuel Roilides; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2013-05-06       Impact factor: 9.079

5.  Necrotizing mycosis due to Verruconis gallopava in an immunocompetent patient.

Authors:  Christian Geltner; Sieglinde Sorschag; Birgit Willinger; Thomas Jaritz; Zoran Saric; Cornelia Lass-Flörl
Journal:  Infection       Date:  2015-03-06       Impact factor: 3.553

6.  Occurrence of Ochroconis and Verruconis species in clinical specimens from the United States.

Authors:  Alejandra Giraldo; Deanna A Sutton; Kittipan Samerpitak; G Sybren de Hoog; Nathan P Wiederhold; Josep Guarro; Josepa Gené
Journal:  J Clin Microbiol       Date:  2014-09-17       Impact factor: 5.948

Review 7.  Emerging fungal infections in solid organ transplant recipients.

Authors:  Shmuel Shoham
Journal:  Infect Dis Clin North Am       Date:  2013-04-17       Impact factor: 5.982

Review 8.  Mold infections of the central nervous system.

Authors:  Matthew McCarthy; Axel Rosengart; Audrey N Schuetz; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  N Engl J Med       Date:  2014-07-10       Impact factor: 91.245

9.  Verruconis gallopava cardiac and endovascular infection with dissemination after renal transplantation: Case report and lessons learned.

Authors:  Zoe Jennings; Kathy Kable; Catriona L Halliday; Brian J Nankivell; Jen Kok; Germaine Wong; Sharon C-A Chen
Journal:  Med Mycol Case Rep       Date:  2016-12-13

10.  Ochroconis gallopava bronchitis mimicking haemoptysis in a patient with bronchiectasis.

Authors:  M Bernasconi; C Voinea; P M Hauser; L P Nicod; R Lazor
Journal:  Respir Med Case Rep       Date:  2017-08-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.